<DOC>
	<DOCNO>NCT02102126</DOCNO>
	<brief_summary>The ENSURE study multi-center , prospective , single-blind , randomize , control study effect renal denervation arterial stiffness haemodynamics subject uncontrolled hypertension . Bilateral renal denervation perform use catheter , deliver radiofrequency energy luminal surface renal artery .</brief_summary>
	<brief_title>Effect Renal deNervation Arterial Stiffness Haemodynamics Patients With UncontRolled hypErtension ( ENSURE )</brief_title>
	<detailed_description>Biomarkers identify responder It know one fifth patient systolic BP reduction le 10 mmHg renal denervation , failure HTN-3 study may partly attributable point . Therefore , critical identify biomarker order screen patient would benefit catheter-based therapy . Some investigator indicate impaired cardiac baroreflex sensitivity may predict response renal denervation therapy [ 13 ] . In addition , also several candidate . 1 . Arterial stiffness As indicated Mitchell GF , proven , Framingham study , arterial stiffness major contributor onset development high BP , consequence [ 14 ] . Furthermore , physiological viewpoint , age-related arterial remodel closely associate elevation sympathetic activity [ 15 ] , report renal denervation lead decrease patient ' arterial stiffness [ 16 ] . However , remain unclear whether patient severe arterial stiffening would better benefit treatment . 2 . Endocrinic biomarker Theoretically , renal denervation decrease patient ' BP mainly decrease local systematical sympathetic tone renin-angiotensin-aldosterone ( RAS ) activity . However , remain unclear patient high renin level biomarkers would improve response novel therapy . Other BP-related parameter Based publish data HTN-1/2 consider worldwide marketing catheter-based device , clinical investigation need continue limited efficacy BP reduction safety . Several BP-related parameter great interest investigate novel denervation therapy . 1 . Blood pressure variability In 2010 , Rothwell colleague indicate increased BP variability significantly associate cardiovascular mortality stroke [ 17 ] . We find XCELLENT study , rather antihypertensive agent , amlodipine agent significantly decrease patient ' BP variability 24-hour beat-to-beat setting , partly ameliorate autonomic nervous system ( ANS ) [ 18,19 ] . Renal denervation therapy denervate sympathetic nerve surround bilateral renal artery radiofrequency , theoretically , treatment many potentially impact patient 's ANS , patient ' BP variability . With development 24-hour aortic ABPM name MOBIL-O-GRAPH , commercially available validated invasive method [ 20 ] , may investigate impact renal denervation 24-hour brachial BP variability also 24-hour aortic BP variability . 2 . Aortic blood pressure Several investigation indicate superiority central BP brachial BP association target organ damage [ 21,22 ] , interest investigate efficacy renal denervation brachial BP also central BP . Some investigation indicate renal denervation also reduce patient ' aortic BP augmentation index [ 15,23 ] . However , development 24-hour aortic ABPM mention , make sense investigate influence renal denervation ambulatory aortic BP . 3 . Asymptomatic target organ damage As indicated HTN-1/2 , even evaluate 24-hour ABPM , renal denervation therapy decrease patient ' BP 20/12 mmHg systolic/diastolic BP , respectively [ 6 ] . Many asymptomatic target organ damage ( TOD ) actually BP-related , novel treatment would impact patient ' TOD , include pulse wave velocity ( PWV ) , echocardiograph-diagnosed electrocardiograph-diagnosed leave ventricular hypertrophy ( LVH ) , carotid intima-media thickness ( IMT ) plaque , microalbuminuria , still unknown , even involve establish target organ damage , cardiac remodeling leave ventricular diastolic dysfunction . Some investigator indict effect renal denervation PWV [ 16 ] , leave ventricular mass diastolic dysfunction [ 24 ] , systematic investigation efficacy renal denervation BP-related target organ damage still warrant . REFERENCE 13 . Zuern CS , Eick C , Rizas KD , Bauer S , Langer H , Gawaz M , Bauer A . Impaired cardiac baroreflex sensitivity predict response renal sympathetic denervation patient resistant hypertension . J Am Coll Cardiol 2013 . In press . 14 . Kaess BM , Rong J , Larson MG , Hamburg NM , Vita JA , Levy D , Benjamin EJ , Vasan RS , Mitchell GF . Aortic stiffness , blood pressure progression , incident hypertension . JAMA 2012 ; 308 : 875-881 . 15 . Dinenno FA , Jones PP , Seals DR , Tanaka H. Age-associated arterial wall thickening related elevation sympathetic activity healthy human . Am J Physiol Heart Circ Physiol 2000 ; 278 : H1205-H1210 . 16 . Brandt MC , Reda S , Mahfoud F , Lenski M , Böhm M , Hoppe UC . Effects renal sympathetic denervation arterial stiffness central hemodynamics patient resistant hypertension . J Am Coll Cardiol 2012 ; 60 : 1956-1965 . 17 . Rothwell PM , Howard SC , Dolan E , O'Brien E , Dobson JE , Dahlöf B , Sever PS , Poulter NR . Prognostic significance visit-to-visit variability , maximum systolic blood pressure , episodic hypertension . Lancet 2010 ; 375 : 895-905 . 18 . Zhang Y , Agnoletti D , Blacher J , Safar ME . Effect antihypertensive agent blood pressure variability : X-CELLENT study . Hypertension 2011 ; 58 : 155-160 . 19 . Zhang Y , Agnoletti D , Blacher J , Safar ME . Blood pressure variability relation autonomic nervous system dysregulation : X-CELLENT study . Hypertens Res 2012 ; 35 : 399-403 . 20 . Weber T , Wassertheurer S , Rammer M , Maurer E , Hametner B , Mayer CC , Kropf J , Eber B. Validation brachial cuff-based method estimate central systolic blood pressure . Hypertension 2011 ; 58 : 825-832 . 21 . Zhang Y , Li Y , Ding FH , Sheng CS , Huang QF , Wang JG . Cardiac structure function relation central blood pressure component Chinese . J Hypertens 2011 ; 29 : 2462-2468 . 22 . Roman MJ , Okin PM , Kizer JR , Lee ET , Howard BV , Devereux RB . Relations central brachial blood pressure leave ventricular hypertrophy geometry : Strong Heart Study . J Hypertens 2010 ; 28 : 384-388 . 23 . Hering D , Lambert EA , Marusic P , Ika-Sari C , Walton AS , Krum H , Sobotka PA , Mahfoud F , Böhm M , Lambert GW , Esler MD , Schlaich MP . Renal nerve ablation reduces augmentation index patient resistant hypertension . J Hypertens 2013 ; 31 : 1893-1900 . 24 . Brandt MC , Mahfoud F , Reda S , Schirmer SH , Erdmann E , Bohm M , Hoppe UC . Renal sympathetic denervation reduces leave ventricular hypertrophy improve cardiac function patient resistant hypertension . J Am Coll Cardiol 2012 ; 59 : 901-909 .</detailed_description>
	<criteria>Individual ≥ 18 ≤ 80 year old time randomization . Individual receive stable medication regimen include full tolerate dos 3 antihypertensive medication different class , one must diuretic ( change minimum 2 week prior screen ) expect maintain without change least 6 month . Individual office systolic blood pressure ( SBP ) ≥ 160 mmHg base average 3 blood pressure reading measure initial screen visit confirmatory screen visit Individual estimate glomerular filtration rate ( eGFR ) &lt; 45 mL/min/1.73 m2 Individual Ambulatory Blood Pressure Monitoring ( ABPM ) 24 hour average SBP &lt; 135 mmHg Individual type 1 diabetes mellitus Individual require chronic oxygen support mechanical ventilation ( e.g. , tracheostomy , CPAP , BiPAP ) nocturnal respiratory support sleep apnea . Individual primary pulmonary hypertension . Individual pregnant , nurse planning pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Renal denervation therapy</keyword>
	<keyword>Aortic blood pressure</keyword>
	<keyword>Blood pressure variability</keyword>
	<keyword>Arterial stiffness</keyword>
	<keyword>Target organ damage</keyword>
	<keyword>Biomarker</keyword>
</DOC>